The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer.
Lv W, Li T, Wang S, Wang H, Li X, Zhang S, Wang L, Xu Y, Wei W.
Lv W, et al. Among authors: wang h, wang l, wang s.
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211045206. doi: 10.1177/15330338211045206.
Technol Cancer Res Treat. 2021.
PMID: 34605326
Free PMC article.
Review.